rs955845

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001198999.2(SEMA6D):​c.-54-62783A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 152,118 control chromosomes in the GnomAD database, including 8,457 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 8457 hom., cov: 32)

Consequence

SEMA6D
NM_001198999.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.849

Publications

2 publications found
Variant links:
Genes affected
SEMA6D (HGNC:16770): (semaphorin 6D) Semaphorins are a large family, including both secreted and membrane associated proteins, many of which have been implicated as inhibitors or chemorepellents in axon pathfinding, fasciculation and branching, and target selection. All semaphorins possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Additional sequence motifs C-terminal to the semaphorin domain allow classification into distinct subfamilies. Results demonstrate that transmembrane semaphorins, like the secreted ones, can act as repulsive axon guidance cues. This gene encodes a class 6 vertebrate transmembrane semaphorin that demonstrates alternative splicing. Several transcript variants have been identified and expression of the distinct encoded isoforms is thought to be regulated in a tissue- and development-dependent manner. [provided by RefSeq, Nov 2010]
SEMA6D Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001198999.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.408 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001198999.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEMA6D
NM_001198999.2
c.-54-62783A>G
intron
N/ANP_001185928.1Q8NFY4-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEMA6D
ENST00000558014.5
TSL:1
c.-54-62783A>G
intron
N/AENSP00000452815.1Q8NFY4-2
SEMA6D
ENST00000559184.5
TSL:4
c.-54-62783A>G
intron
N/AENSP00000453097.1H0YL82
SEMA6D
ENST00000560636.5
TSL:4
c.-54-62783A>G
intron
N/AENSP00000453420.1

Frequencies

GnomAD3 genomes
AF:
0.298
AC:
45317
AN:
152000
Hom.:
8454
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0810
Gnomad AMI
AF:
0.370
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.409
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.272
Gnomad FIN
AF:
0.345
Gnomad MID
AF:
0.443
Gnomad NFE
AF:
0.412
Gnomad OTH
AF:
0.332
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.298
AC:
45317
AN:
152118
Hom.:
8457
Cov.:
32
AF XY:
0.294
AC XY:
21877
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.0808
AC:
3356
AN:
41552
American (AMR)
AF:
0.343
AC:
5236
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.409
AC:
1420
AN:
3472
East Asian (EAS)
AF:
0.232
AC:
1197
AN:
5166
South Asian (SAS)
AF:
0.274
AC:
1318
AN:
4814
European-Finnish (FIN)
AF:
0.345
AC:
3643
AN:
10570
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.412
AC:
27988
AN:
67976
Other (OTH)
AF:
0.328
AC:
692
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1486
2972
4457
5943
7429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
1640
Bravo
AF:
0.292
Asia WGS
AF:
0.243
AC:
844
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.47
DANN
Benign
0.81
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs955845;
hg19: chr15-47989159;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.